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1. 
Shock may be described as a syndrome of peripheral 
vascular i!'l..8ufficiency :In v1hich the effective circulatir.:.g 
blood volwne is reduced, accompanied by depression of many 
systems. The impaired general cir'culation causes diminished 
tissue perfusion and decomper~ation of the microcirculat-
26 
ion. The result is a basic defect in cellular perfusion. 
Although the etj .. ology and mechanism of shock may vary, the 
final common physiological lesion is cellular hypoxia. 
Hemorrhage or another type of metabo11.c insult may be the 
initial lesion, but regardless of etiology all types of 
shock rapidly form a similar syndrome since they sbEvre the 
56 
same basic defect of cellular l1Ypoxia. As stated by 
30 
Haldane, uAnoxia not only stops the machine, rrut v;rrecks 
th~1 machiner"'lJ. II 
Hemorrhagic shock has been a misunderstood and 
frequently mistreated clinical syndrome. It is a complex 
entity that involves many etiologic factors, and becomes 
more complicated when combin~tions of these factors are 
the causes of circulatory collapse. Know·ledge concerning 
shock has increased steadily over the yeal~ as research 
has improved our understandir~ of basic biochemical and 
phYSiologic mechanisms. New research tools and advanced 
methods of monitoring phYSiologic parameters have also 
allOilfed a more scient:tflc approacrl to understanding the 
mechanisms and management of hemorrhagic shock. HOvfever, 
the gro·~rth of concepts leading to the present understand-
i11;5 of shock requires an appr'eciation of the historical 
\.,~ 
2. 
background involved. 
HISTORY 
The early defir..itiol1..8 of shock were based entirely 
on clinic1:;11 description and the initial usage of the term . 
60 
arose from observation of the l'lounded. on the battlefield. 
Shock 1,'1as used to denote a condition l"here the injury, on 
superficial examina.tion appeared too small to account for 
58 
the seeming collapse of vital processes. Warren's 
definition of shoo1r, If A momenta!"'J pause in the act of 
death," implies that the study of shock is the study of 
impending death. Gradually the prostration, hypotension, 
pallor, coldness, moisture of the skin, collapse of super-
ficial veins, suppression of urine formation, and obtunded. 
mental status seen in battle casualties came to be recog-
37 
nized in other conditions such as cholera. In 1831 Latta 
made a monumental contribution to the u-1'lderstandi!l(£ of 
sl1.ock. 1j"ithout :r:n"'ecedent to direct him he proceeded to 
infuse 330 ounces of saline intravenously into a cholera 
patient in 12 hours, and reported dramatic clinical 
improvement. 
The advent of experimental physiology and the use of 
the kymograph focused attention on the measurement of 
arterial blood pressure, and confinaed that hypotens:ton 
iias one of the most con...l:3istent accompaniments of shock. 
Recogn1 tion of the control of the heart and blood vessels 
by a vasomotor center acting by itTaY of nervous p'3.th"kiays 
prompted the concepts of vasomotor paralysis and of' cardiac 
failure resulting from reflex vagal hyperactivity. 'rhis 
neurogen1 .. c definition of' shock '\tras summarized by 
27 
Groenigen in 1885. He proposed that shock began as 
a state of intensive nervous stimulation and was followed 
by vasomotor exhaustion. 
15 
At the end of the 19th centu17 Crile developed 
an experimental model of hemorrhagi.c shock. His 1tfork 
resulted in a systematiC definition of shock in the 
experimental animal. He clearly documented the lowered 
venous pressure ln hypovolemic shock, the accelers.tion 
and deepening of respiration follol'ling hemorrha,ge and the 
response of the shocked animals to infusion of warm saline. 
This latter respon.~e w'as an indj.oation to Cri.le that the 
oardiac aotion was normal in shock and that the defeot 
was largely one of impaired venous return. 
'ilar has almost invariably stimulated interest in the 
definition and therapy of shock, and the war of 1914-1918 
was no exception.. From observations made on the battle-
12 
field and in laboratory investigation, Cannon attempted 
to explain the hypotenSion of shock in terms of cardiac 
failure, loss of vasomotor tone, fall in blood volume, 
or stagnation in venous reservoirs. In 1917 CarJlon used 
the then nei<l Van Slyke apparatus to document a correlation 
bet1.'feen the 10"\1 blood pressure and the reduction i.n alkali 
reserve. He believed that the fall in the alkali reserve 
'vms due to t,he accumulation of fixed acids, such as lactic 
acid, and recognized that this "\vas due to impaj,red oxygen 
transport. The acidosis "faS :ldentified as a secondary 
phenomenon that "\,las responsive to the adminj.stration of 
sodium bicarbonate. When the volwue of the war wounded 
'{vaS studied by means of dye dilution methods, it ",'faS 
found that the severity of shock correlated '!tlith the 
reduction in blood volume. Cannon then deflned "\1ound 
shock as a discrepancy between blood volume and vascular 
capacity. 
Other vlorkers continued to add to the body of knovl-
ledge dur:lng the follo ... ,ing years. Recent investigations 
have concentrated largely on the elucidation of the 
hemodynamic and biochemical events in experimental canine 
29,35,40 
models using endotoxin or graded hemorrhage. 
AlthOugh a considerable body of knowledge has emerged 
from this vlOrk, much cannot be transposed readily from 
4. 
the artificlal experimental model to the clinical situation. 
The comulexities of human shock are in reality poorly 
. 60 
defined. The age of the patient, past medical 
history, possibility of severe underlying disease, and 
the function of vltal organs are varil;;1.ble factors that 
may contrlbute to ci,rculatory collapse. All this infor-
mation is not readily quantitatable nor transferable from 
one case to another, but is vital in the interpretation 
and analysls of shock data. 
Tradit:i.onally, physicians regard shock from the 
circulatory vle'dpoint. Blood pressure, heart rate and 
venous pressure are the three most readily measured, and 
hence, the most COlUill0nly cons idered variables. Hm1ever, 
an absolute value of any one par1.;tmeter i.s seldom a 
satisfactory basis for determining the presence or the 
severity of shock. Shock has often been regarded as a 
problem in arteril3.1 pressure \'lh(:;n in fact a more satis-
factory common denominator ';10uld appear to be cellular 
d~~age due to inadequate capillary flow and resulting 
2,56 
hypoxia. While a falling blood pressure is almost 
invariable in shock, the hypoten.gion mtlY be a relatively 
late development in the course of events. Similarly, 
"",lhile the degree of hypote!'l..sion often correlates vdth the 
5. 
sever:i.ty of the shock, there may be exceptions. Conversely J 
in severely shocked patients the blood pressure may be 
raised 1dth vasopressors to normal or hypertensive levels, 
21,31,32 
but the tlssue blood floN' is progressively reduced. 
Distribution of blood flO'1'1 to nutritive or non-nutritive 
vessels is just as important as al"1:.erlal pressure or 
cardiac output. 
In :tts Simplest form shock is largely a problem of 
blood gas transport and exchange at the pulmonar;:y- and 
cellular levels. Although cellular disorganization 
produced by a prolor"ged decrease in blood fl0i1 may ori13i-
nate from the breakdovll'l of mitochondrial enzyme systems 
or the release of hydrolases from lysosomes, it must be 
recognized clinically as a decrease in the function of 
an orGan system such as the myocardium, the kidney, or 
6. 
the lun.gs. Improvement in the CH,re of the shock pat ient , 
therefore, can be achieved by close and continuous obser-
vation of the patient and the changing clinical picture, 
repeated measurements of organ system functions by available 
techniques, and the appropriate use of fluids, solutes, 
and drugs. The 011f1..ical mftnagement of shook demands 
unremi,tt1ng personal attent::Lon beoause of the need to 
oontinuously monitor and treat hypovolemia, respiratory 
disorders, myocardial decom;~~el1satiol1, renal failure and 
so forth. 
PATHOPHYSIOLOGY OF SHOCK 
An understanding of the changes result:Lng in the 
progreSSion of events resultin~ in shock is essential 
for proper therapy. ]"lany of the cha~'3es are time related 
and val""iable, depending upon the eA~ent of the injury. 
In hemorrhagic shock the primary problem is hypovolemia 
2,18,50 
or decreased effective circulating blood volume. 
17,55 
There is decreased venous return. 
Cardiac output is decreased and the arterial blood 
pressure falls causing stimulation of baroreceptors. This 
results in an increased heart rate and the myocardium 
2,16 
contracts "'lith increased force. 
31 
Decreased capillary blood flow occurs. 
l"'nere is neuroendocrine stimulation resulting in 
release of antidiuretic hormone and adrenocoticotropic 
'+2 
hormone. The output of l7-bydroxycortico1d, aldosterone 
and catecholamines is increased. The renin-angiotensin 
mechanism is activated. Arterial and venous vasocor~tric-
tion are produced. Hepatic glycogen breakdm'ln is stimulated 
producing hyperglycemia and eventually hyperkalemia and 
glycogen depletion. Hypoglycemia may occur in terminal 
stages, since hist~m.ine, serotonin, and vasoactive 
polypeptide release may increase. 
Available cardiac output to skin, skeletal muscle, 
kidneys, and the splancrillic bed is reclistri buted by both 
arteriEd and venous vasoconstri,ction to the central 
circulation, especially the heart and brain. 
Capillary refillir..g of plasma volume occurs Hith 
3 
resuTting hemodilution. Adrenal steroids and the renil"l-
an~$iotensin mechftnism may part'Jicipate in thi.s refilling. 
14 
Hyperventilation occurs. Initially this is probably 
secondary to decreased central nervous system blood flow. 
Respiratory alltalosis may follow the initial hyperventi.la-
tion and further decrease cerebral blood flow' by a fall 
in arterial pC02 • Later, hyperventilation from metabolic 
acidosis occurs. 
Cellular hypoxia, decreased aerobic oxidation through 
the Krebs tricarboxylic acid cycle and the electron 
transport system and an increa.se in anaerobl,c glycolysis 
2,9,52 
by the Embden-Meyerhoff pathway occurs. Blood 
levels of lactate and PYl41Vate are both increased initially, 
34 
but later, blood lactate increases more 'tr..an PYr'..lvate. 
Increased acid metabolites produce metabolic acidosis and 
8. 
blood :pH and carbon dioxide content fall. 
Tissue adenosine triphosphate stores decrease, and 
levels of inorganic phosphate increase. Glucose utilization 
52 
is decreased, and alpha amino nitrogen levels increase. 
Hyponatremia and hyperltalemia are produced. 
There j.s depression of the reticuloendothelial system 
'Vlith decreased phagocytosis. Sludgil1..g and intravascular 
31,32 
red cell aggregation may occur. 
There may be morphologiC intracellular changes of 
cytoplasm ''lith edema and rni tochondrie.l disorganization 
as well as increased levels of lysosomal hydrolase enzT&es 
t:;? 
-,-
and proteases in peripheral blood. 
Regional vasodilatation and pooling of blood 2clong 
itlith the other changes eventually lead to cell death. 
The e1'fects of hemorrl1age and decreased. blood 1'10111 on 
various organs can be discussed only in general terms .. 
In the individual patient, these ~vill depend on the pres-
ence of pre-existing organ or vascular d:tsease. Hovlever, 
every organ participates in the shock syndrome by altering 
its function as a defense against the metabolic insult .. 
During shock, rel'lal blood 1'1011 is decreased due to 
vasoconstriction of the reIk'll arteries. There :i.s an 
intrarel1£l.l redistribution of blood flo,,! from the cortex 
favoril1.g the medulla. A decreased glomerular filtratiol1 
rate and oillgur:le~ are noted. Hourly urine volumes fall 
below 30 milliliters. There is a decrease in medulla~J 
sodium vIith loss of the medullary hyperosmolar zone and 
loss of the countercurrent concentratir~ system. Activation 
of the renin-ane3iotensin mechanism occurs. Eventually 
tubular necrosis accentuated by pigment excretion of 
azotemia, hyperkalemia, and acidos:i..s occurs • 
16 
The initial ctlrd1ac response is a decrease in output. 
The nonnal heart responds to ch;:tnging venous return by 
caro:i.etc output adjustments, and over significant periods 
the venous return must equal ca.rdiac output. vlhen he111or-
rhage has occurred, venous return is altered by peripheral 
factors (c or...strict ion, aggregation) as 14'ell as by the 
volume lost, and cardiac output falls in respol~e to 
diL1inished venous return. This is counteracted by the 
pressure receptors in the aortic e~rch and the carotid sinus 
VJ'hich, 1n response to hypotension, induce a reflex increase 
in heart rate and stroke volume. The coronary circulation 
has an extraordinary capacity for oX'.rgen extraction, but e~t 
101.'1 pressure levels it may not be able to deliver sufficient 
oxygen to the myocclrdiu.m to maintain contractility. 
Endogenous norepinephrine 'dill increase myocardial con-
tractile force, but 1'iill also increase the oxygen requj"re-
2 
ments of the myocardium. Acidosis may cause further 
deterioration of myocardial function. Pre-existing coronary 
artery disease may lead to myocardial ini'arction. 
Decreased pu]monary blood flow may contribute to 
1+6 
hypoxia and carbon dioxide retention. As shock progresses 
there is a loss of pulmonary elasticity clue to the 
sequestration of flu::td in the interstital space and 
increased capillary permeability 'fiith pulmonary edema. 
Sequestration of red blood cells and intravascular coag-
31 
ulation within the pulmonary capillaries may occur. 
10. 
In the liver there 1s a marked reduction in the stores 
of adenosine triphosphate and decreased ability to break 
down lactate and detoxify other substances. Decreased 
blood flo'Vl to the gastrointestinal tract during shocl<:: 
results in mucosal ischemia and a decrease in mucin 
production i'lhlch favors peptic ulceration. 
The changes occuring after hemorrha~e in normal man 
44 
have been extensively studied by Moore. 
F.ECOGNITION 
Pure hemorrhage is a frequent cause of shock in massive 
gastrointestinal bleedin.,.g, penetrating tr:~n.lIlla Ivi th injury 
to solid viscera such as liver, spleen, kidney or artery, 
r .... lptured aneurysm, etc. The clinical findings in the 
resulti!'l.g hypovolemic shock are based largely on general-
ized vasoconstriction in the periphery al1d diminished 
volume return to the right heart 1.;1 th decreased cardi.ac 
output. The effect of excess endogenous vasopressors 
explair...s the cool, clammy skin "tli th sympathetic overacti v-
ity. Similarly, tachycaroia, tachypnea, and diastolic 
hypertension are signs of maximal peripheral res:'Lstance 
compe!'l..sating for the early modest decrease in cardiac 
output. HO'ti'ever, continued fall in cardiac output causes 
11. 
arterial hypotension unless treatment is undertaken. 
Olinical assessment of the magill tude of the hemor-
rhage is useful in planning therapy. The capillary blanch-
ing test is performed by blanching the skin of the forehead 
or hypothe!'..:~r eminence t'Jr thumb pressure; normal cutaneous 
circulation '('ii11 return in 1.25 to 1.5 seconds. Delay in 
refill is a crude :i.ndication of 20 per cent blood vol'lune 
deficit or greater. Patlents in frank shock either have 
insufficient cutaneous circulation for blanching to be 
evj.dent, or demonstrate marked delay in refill. Another 
f::;uide to the 13 cope of the bleed:'Lng Vlhich has occurred has 
to do vdth having the patient sit up suddenly; "1hen blood 
losses 1.n excess of 15 per cent of circulati:ng volU!1J.e exist, 
sudden cerebral j.sohemia vlith dizziness, nausea or faintir..g 
f0110",IS assumption of the upright position. 
The f011ov1ing maneuvers may be undert'iken IiThen a pat:tent 
:i.s admitted to the hospital vlith massive bleedlllJ! : 
'"'"' 
1. Intravenous catheter(s) inserted. 
2. Blood to be typed and cross-matched is obtninQd. 
~? Fluid a,nd solute relJlacement is st8"ried. 
11-. Urinar'"j bladder cathetel'" is inserted and hourly urine 
volUrll.e measured. 
5. Nasogastric tube is pl?3.ced ~l.f source of bleeding is 
obscure. 
6. Vital signs including pulse pressure are measured and 
recorded at speclflc lntern.rals. 
7. Extent of trau~a, if any, :ts evaluated. 
12. 
8. Hematocrit is obtained. lilay cor .... gider obtaining blood 
volu..'1H~ if available. 
9. Central venous pressure catheter is inserted if not 
previously done as IX:trt of 1. above .. 
CElfrR.liL VENOUS PRESSm":tE !~orn:frORING 
A valuable 8,sset in the diagnosis and treatment of 
shock :i.s a central venous catheter--a large ca.liber plastic 
catheter inserted into tl1e superior vena cava by way of the 
antecubltal, e:r;:terne"l jugu.lar or subclavian vein. Central 
VenO"LlS pressure measurement, alont~ vlith arterial blood 
pressure ,:lnd urine output measu.rements, has greatly improved 
2 
the care of the patient in shock. A..'I1 inferior vena cava. 
catheter influenced by abdominal pressure or a catheter in 
the vein of an extremity do not accurately reflect right 
atrial pressure, and are not suitable for monitoring central 
venous pressure. The catheter can be used for fluid 
administration and blood sampling in addition to pressure 
measurements. 
A central venous :pressure catheter should be used 
"\'lh,enever a pa,tient does not respond rapldly to "That is 
believed to be adequate replacement of vascular volume. 
Normal right atr:tal pressure is zero to 10 centimetel"S of 
'\f8,ter or 2 to 8 millimeters He;. If' a patient does not 
respond satisfactorily to VOlUjl1e replacement and the central 
venous pressure 1s low, volume restoration should be 
continued u.."'ltll the central venous pressure begins to rise. 
13. 
It is difficult to give an absolute level tl1,;:\.t can be 
used as an end point, but 15 centi.meters of 1'later or above 
indicates begim1.ir...g circulatory overload. This is usually 
due to myocardial failure and is not a reflection of 
hypertlolend.a. How'ever, additional fluid administration 
must be carefully cons:Ldered.. Other measures such as 
dlg:Ltalis, other drugs having an inotropic cardiac effect, 
13 
or vasodi,lator agents may be required. The subject of 
central venous pressure monitorir~ has recently been 
8 
revi el4'ed by BOrr0'll1 and Es oa1"'0 • 
Patients requir:Lng positive pressure venti.lation may 
ha:ve an elevated central venous pressure on this basls, 
~ with persistent t~rpovolemia. Central venous pressure 
may also be normal or high in hypovolemic patients if there 
is poor coronal~ arte~J perfusion decreasing right 
ventricular function. As corona_~J perfUSion is improved 
by volume re~placement, central venous pressure may fall. 
There are other causes of a false elevation of central 
venous pressure 1tlhlch must be kept in mind: mechanical 
obstrtlction of the venous retul"n, as seen in cardiac 
tampor.,ade, mediastin.:-'ll compression, or venous thrombosis; 
hemothorax !J.nd pneumothorax; the administration of vaso-
constrictors; and impro'per placement of the catheter. 
"fl,ll of these fact ors \vil1 produce a. high central venous 
pressure. 
REPLACEr.rEIIT OF BLOOD, FLUID lU\T!) VOLUME 
Hypovolemia must be considered initially vlith shock 
from any cause, since fluid or blood administration may 
be heplful even if no losses are suspected or can be 
1 
14. 
documented. A helpful concept that has evol ... ,red j"s to achieve 
an effective circulating blood volume. It is the best 
e,-uide to the volume of blood and fluids needed, and one 
of' the most common problems in the treatment of shock 
caused by hypovolemia is inadequate volume replacement. 
23,21+ 
The vascular space is not a static volume. 
Vasoconstriction of resj.stance vessels, terll1inal arterIes 
ELnd arterioles, may divert blood from various regions, but 
the largest change in vascular bed volume probs.bly occurs 
in capacitance vessels, the capillar:les, venules, and 
veiX'..s. Constriction of capacitance vessels in shock reduces 
the peripheral vascular volume and increases the central 
volume to a variable extent. 
Treatment is best based on giving enough volume 
replacement to achieve a reasonable arterial blood pressure, 
good urine output, and good peripheral perfUSion as judged 
by palpable peripheral pulses and lilarm, dry skin vlithout 
ele~qE;<tion of ri{;,.'1t atr:tal pressure. This represents an 
effective circulating blood volume. 
The significance of a median venous pressure, 6 to 10 
centimeters of "\vater, can be determined by a test infusion 
of fluid. An electrolyte solution 1s a&~inistered fairly 
rap1"dly and the centrEtl venous pressure is measured after 
every 100 cubic centimeters of fluid has been administered. 
15. 
If the central venous })ressure does not increase ;nore than 
5 centimeters during the i,ni'usion of the first 500 centimeters 
and returns to i'lithin 2 to 3 centimeters after 15 minutes 
of infus~ .. Qn, th:l.s '"IQuld suggest th1:tt the heart tolerates 
the j .. ncrease \1"ell and tha.t further fluid is most likely 
required. On the other hand, an increa.se in central venous 
pressure ''lould indicate that the heart is not capable of 
handlip~ these additional quantities of fluid. 
Estimc'ltion of blood loss follo\'liJ:"l..g trauma. is cllfficult. 
RiddeXl loss after injury, particularlyvrlth fractures of 
the femur or pelvis and 'IIith retropel"itoneal hematomas, often 
escapes attention. Replacement is better based upon 
achieving an effective clrculatlng blood volLUlle than 
upon attempts at calculation 'l,,ri th a bala.nce sheet. 
Volume replacement should be provided as rapidly as 
it is needed and tolerated. The ul"gency of fluid or blood 
administratiol1. to the hypovolemic patient must be stressed, 
since the longer shock persists, the more devastating its 
effect and the more difficult treatment becomes. Isotonic 
saline, Ri~'5erts lactate solution, or clini.c'O'"l dextran can 
be given \"1h11e blood is belng 'Jroperly cross-matcheo .• 
CH v1ng such fluids in the interim period1!1ith moderate 
hemorrhage may have a.dd! tiortal advantages. It has been 
f01LiJ.d that cardie.,c outpu.t and oxygen consumption are more 
rapio_ly increased by gi ying fluids contal:ning no red 
cells in the initial treatment of shock. T"h,is may be due 
to decreased viscosity of the blood and better flo,,; 
16. 
characteristicsvlith hemo(lilution. With exsanc~uinating 
hemo::Ft'hage, type 0 Rh-negative blood 'dith a lo,,~' antibody 
titer can be used immediately if needed. Several infusion 
si tea ,11th large catheters and pu.mpir.,g devioes may be 
required. 
~'11:1ile shock is bei11g tree.ted , definitive treatment of 
the I'TOunds or sites of hemorrhage must be started. It may 
not be possible to achieve n01""tl1al cardiovasculclr function 
j.f blood loss contimles. Circulatory support must be 
suffioient to maintain coronar-.1, cerebral, and renal 
function vlhile the patient is transported to the operating 
room or other suitable facility. 
The treatment of blood loss is '!tiith blood trarJ.Sfusion, 
but blood alone may not be the best replacement solution. 
Saline solutions In addition seem to be helpful, sinoe there 
seems to be an increased cape.city or increased requirement 
of the c1.,rculation for blood volume to maintain pressure 
21 
and flow in late or severe shock. 
45 
have been sumi'narized by Moore. 
The reasons for this 
It has been hypothesized 
that tl1.e increased sodiu..m speuce a,tld need for saline soluvt-
ions 111 th trauma and shock may be from a take-up of sodi'llI'll 
salts and Vlatel'" by extravascular-extracellular tissue such 
as collagen and ground substance. Ringer's lactate has 
53 
also been found helpful to the injured patient. Shires 
used Ringer's lactate solution initially in patients \i'!ith 
hemorrhagic shock. One or ti'10 liters given rapidly to 
patients vlith marked hypotension often returned the blood 
1 '7 I • 
pressure to normal.. If hemorl"'hage continued, blood 1:ms 
also given.. One advantage to the use of RiT'4.:;er t s lactate 
solution rathel" than isotonic saline is the prevention of 
a fUl"'ther reduct:i.on in pH, vlhich occurs \dth s".:,-line, by buffer 
d:t1ution in an already acidotic patient. HOviever, the 
question has been asked as to 'IThy give more lactc.te I,then 
the blood lactate is already elevated in shoc}r.. Studies 
have found that 1'lhen Rir'.L(,;erfs lactate solution is given to 
an animal in shoc1r, the blood lactate level rapidly decreases 
if blood flovr and cardiac output are improved. The 
51+ 
excess levels of lactate quickly return to normal .. 
f~>ihen blood loss is replaced I,ri.th electrolyte or 
colloid solutions it is at the expense of reduction of 
protein concentration, hema .. tocrit, C'.nd oxygen-carryi:.t1.g 
capacity.. ~"lere is little kno'lln about the potential 
difficulties of :protein cUlution except that edema. may result 
due to hypoproteinemia. It has been found that \'7hen blood 
vollL'1le is restored 1;ri th RiT'..ger f s lactate solution, as 
COml)ared ",lith blood, a marked. reduction in red cell mass 
54 
did not ir.hibit improvement ~Ln oxidative metabolism. 
Blood as commonly preserved. and stored in 11 blood 
bank is an unphysiologic solution. It is freql'tently 
stored in aci.d-ci,trate-dextrose solut:lon, and 1iThen rece:i:ved 
for use it is usually cold. The pH ranges from 6.6 to 7, 
;]cud there is no ionized cJ.lcium due to a 30 % excess of 
citrate. The plasma potassium levels may also be elevated. 
T:"1ese abnormalities present no 'orob1e111 1;\Then sma.ll quantit:tes 
18. 
of blood are given. Oi trate can be rapiclly metabol:]"zed by 
the liver to bicarbonate C'lnd calcium. is mobilized from 
body stores. The potasSi1.;llU ls rapidly dlstr:i.buted in body 
fluids. In patients requiring massive or contlnuir..e; blood 
replacement, or "'iihere shock is complicated by hepatlc or 
renal disease, c1 trate is not metabolized rap1clly and may 
decrease ionized calcium. Acidosis may be increased and 
the body temperature reduced. These abnormalities along 
'\'lith hyperlr:alemia, may not only reduce ca.rdiac efficiency, 
but ca.n produce c<:lrdi8.c arrest or ventricular fibrillation. 
11 
Bunker and his group found blood citrate levels 
sufficiently high to reduce 1.onized calciu.rrr in the blood 
in patients i,dth hepatic disease or obstruction to hepatic 
circulation l'iith multiple transfusions, or 1.11 any pa.tient 
"lith extremely rapid or proloIltsed infusion of citrated 
blood. They also pointed out the difficulty of predictil'lg 
\IThen thj.s vlOuId occur and the potenti'3.l dcl1lgers of using 
calcium salts empirically. R"1pid administration of calciu..1!l 
ion can produce increased ventricular excital)ility and 
ventricular fibrillation '\',rhich is accentuated by decreased 
28,33 
temperature. 
rv1ANNITOL 
Mannitol is an agent frequently used in shock. It is 
hE:,lpful in protectiT'.{~ the Iddneys and also in the diagnosis 
of acute renal failure. Ma~~itol is a six carbon alcohol 
which is not metabolized. It is rea,dily filtered through 
19. 
the glomerulus, and is not reabsorbed in the rena,1 tllbu.le. 
Even in patients i11th previously negligible urine output 
a11a maxirna.l g,1!ticl1tll"")etic stim1) .. l~~ttion, it generally produces 
an osm.ot:lc diuresis 'iri th urine pr'oductlon. The functions of 
mannitol 1/ih1ch are useful for the patient i11. f3hoclt: are a.s a 
dis.gnostic test for acute renal fililure in the p8 .. t5 .. erlt t,r.t 
o11.guria or anuria, and t1S a protection to the kidney \'i'hen 
it ls threatened th acute tubular necros:ts from lschemla 
!..lnd nephrotoxic sU.bstances such as hemoe;lob::Ln and myo310bin. 
ra:pid intravenous grams of 
an increase in urine flou -unless there is ;:'..cute ol"'Sclnic 
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renal failure. A lack ot respor..se to ttvo such infusions 
ivi·thin three 110urs is a strong indic::,.ti.on of org"mic renal 
failure or acute tubular necrosiS. It Should be noted, 
however, that "11th severe persistent hypovolemia, rnar":'1.itol 
may not ~l.nduce a diureSis u"'ntil this i.s partially corrected. 
Plasma expanders (1.re colloid solutions \'ihich exert 
a colloid osmotic or oncotic pl-'essure across the semiper-
meable capillary membrane and thus remain in the vascular 
compartment for a prolonged period. They may be necessar.:r 
1'"/'hile blood is being prepared or secured si.nce the first 
cOl~ideration in restitution of normal volume is not the 
infusion of red cells to increase oxygen-carrying capacity, 
but, rather, the re-establisThT.ent of normal circulating 
20. 
volume. Colloids effective as plasma expanders are 
similar to albumin and should have a molecular ,veight 
above 50,000 so that they do not leave the circulation 
rapidly. Dextran is currently stockpiled by the Al"'raed 
Forces and is the only plasma expander presently 
recomi11ended by the J:lational Research Council. '1'he dextrans 
are 10n13 chain polysacchal"'ides prepared by the grmrth of 
B-512 strain of Leuconostoc mesenteroides. They are 
hydrolyzed to various molecular "'reights vii th the average 
molecular weight being 78,000, and range of 1.1-5,000 to 
180,000. They are inexpensive, chemically indifferent, 
and electrically uncharged. 
vT.hen dextran is employed for plasma expanSion, and 
trRl1 .... '3fusion of ''11101e blood is anticipated, it is necessaI"lJ 
to dra11 blood fOl" typing and cross-matching prior to the 
dextran infusion, as th.is substance Hill cause some 
agglutiUc;ttlon of red cells on the slide or j.n the test 
tube, making cross-matching difficult. Use of large 
volumes 0:1:" dextran may result in hemodilution, reduced 
oxygen carrying capacity, and diminished e~ithrocyte 
bufferir~. 
An increased bleeding tendency has been noted ,·lith 
dextran, particularly 1rlhen large volumes ar'e given. 
6 
Bloom found that a prolol1cr;ation of bleeding time Vii th 
dextran viaS related to ex})ansion of the bloJd volume 
rather than the level of dextran and noted that this 
occurred ',ri th any plasma vall,liue expander. Dilutj.onal 
21e 
hypoprothrombinemia, hypofibrinogenemia, and platelet 
coating ;;.lith dextran may also playa part. This plus 
hemodilution limj.t the recommended tot,al dose to one to 
t·wo liters. 
Pooled plasma has been considered excellent for 
emergency use as a volttrne expander. Hmvever, processing 
to elimi:tlate the hepatitis vir .... ls through storage or 
heating have not proved completely effective. For this 
reason, the National Research Council Committee on Plasma 
and Plasma Substitutes recommends that the use of' ,,,hole, 
pooled human plasma be discoul"'aged or discontinued unless 
49 
a clear-cut reason can be cited for its unique requirements. 
Human serum albumin "'Tould be excellent for volllil1e expansion, 
but is almost never used for this purpose since it is 
exper..sive and may not be as reacUly available. 
Lmi MOLl:CCULAR I'lEIGHT DEX11RAN 
The microvasculature consists of all vessels ot' 100 
48 
microns or less ;tn size. It consists of precapillary 
arterioles, capillaries, and venules. It is the part of 
the circulation that is involved i.-lith cell nutrition. 
Improvement of 1'lovf in this seqment of the vascular bed 
is the primal:"lJ aim in the treatment of shock. Em-lever, 
it \1'8.6 only T'ecently realized that changes 1.n the fluid 
structure of blood with cell aggregation or sludged 
blood could affect flo'~l in this com:partment. Blood is 
a viscid fluid, and in the microcirculation, vThere flm1 
22. 
may norrllally be SlOrJ or transiently stop, viscosity becomes 
important. LOvi molecular ,'leight or levi' viscous dextran 
1:1ith an average molecular "J'eight of 40,000 1s of interest 
because it seems to have a beneficial effect on the 
25,39 
microcirculat ion. 
This effect of dextran of reversing cell aggregation 
smd reducing blood viscosity seems to be ca1.lSed by t't1"O 
principal mechanisms. One ls a rapid increase in plasma 
vol11.'l1e by pulling interstitial liater into the Circulation, 
11"hlch produces hemodl1uti.on and reduces blood viscosity. 
The second is an influence on the red cell membrane by 
coatiM it or altering the proteln envelope on aggregated 
'"'7 
cells. 
The effects of lOitl molecular 1tleight dextran on 
coagulation seem to be much the same as vd,th clinic:3,l 
dextran. There is some prolongation of bleedir~ time 
because of increased tissue blood flo"l. Therefore, it 
must be used 1dth caution or avoided in patlents 'I'J110 are 
bleeding or mig'ht be bleeding" particularly if mechanical 
hemos tas is 1 s not poss i ble • The final role of 1mV' molecular 
,,;reight dextran in the treatment of shock has not been 
deter.ninec1, but it has proved to be an interesting 
rheologic agent and h'?s stimUlated an entire field of 
vrorthwhile investigation. 
OXYG,EN AND VE~NTIU~rORY ASSISTAl\fCE 
One of the primary defects in shock is a reduced 
23. 
oJC",fgen supply to the tissues. Empirically, oxygen '\1011.10. 
seem to be indicated for all patients in shock. Hmiever, 
in the patient in shock 'I'lith satisfactory ventilation, 
artel"'ial oxygen saturat:1. on viill be nOl''mal, and tissue 
orjger..ation can only be :i.mproved by increasing blood 
flm'i and oxygen delivery. It is necess8.ry to be certa:i.n 
that ventilation is adequate. Airl<iay obstruction and 
inadequate ventilation require correction by endotracheal 
59 
intubation, tracheostomy, or positive pressure ventilation. 
Measurement of arterial blood gases and pH are nec-
essary to determine carbon d:toxide retention, hypoxemia, 
or acidosis which may precipitate or contribute to 
59 
unresponsive shock. 'flh.en pH is less that 7.35 and PC02 
exceeds 46 rom Hg, the patient has respiratory acidosis. 
For practical purposes, v1hen the P02 in arterial blood is 
less than 70 In.-rn Hg (93% saturat ion), oxygen exchange i.s 
def'ective. Respiratory aci()osis usually indicates either 
airway obstrL1ction or inadequate bellol'J"S action because of 
neural, muscular, or mech[-3.nical defic:l.t. r.1echanical 
assj .. st.ance of venti.lation is usually needed. A sharp 
decline in oxygen tension or saturation usually indicates 
shunting through collapsed or cO!l...solidated lung. If this 
shunting effect is not promptly resolved after 'clearing 
obstr-actions or by mechani.cal ventilation, the concentJ:'ation 
of oxygen in inspired ai.:r should be increased to ll·O% or 
greater. After 0:1.73en content of a,rterial blood re"whes 
normal levels, is chemic injury to orgO:3,118 IJ.no. vi tE'_l tissues, 
24. 
:1. no luding the heart, is m:i.nimized. 
VASOPRESSOR AND VASODILATOR AGEN"'TS 
Sympathomimetic drugs are "!'V'idely used by most clinically 
active physicians. Effects of thes drugs comprise 4 
broB.d types: cO!l..stricti.on and dilation of resistance and 
capacitance vessels; inotropic eJld chronotropic actior.J3; 
metabolic effects, such as glycogenolysis and lipolysis; 
end central nervous system stimulation. Sympfttholytic 
dr~gs block one or more of these responses. 
Vasopressor or constrictor dr~gs such as levarterenol 
(Levopbed), meta~-.J!!inol bitartrate (Aramine), and 
phenylephrine (Neosynephrine) have frequently been used 
in the treatment of shock, lX:l.rtlcularly 'dhen blood, fluids, 
and other measures do not raise the blood pressure to a 
36,43 -
satisfactory level. Such agents are practically 
ali-laYs effective in elevat .. i.ng the blood pressure, at least 
transiently, even though the patient may ultimately not 
sUJ':"'.r:lve. There has been a fixation of the arterial blood 
pressure in shock, a.nd frequent ly the blood pres sure 11.<':1S 
been treated rather than the patient. Hovlever, this 
situation is nov; rapidly changing because of the knm·.rledge 
that increased or prolonged vasoconstriction :may be harmful 
and because of the availability of drugs irlhich vIi11 
12 
increase blood :flo'!", rather than blood pressure. Cannon 
in 1923 vlrote that increased arterial pressure vTaS not 
vJho,t vias needect in shock, but ra.ther the need vms for 
increased capillary blood flovl. 
Srmpathetic nervous system receptors may be divided 
into stimulatory or ,!:tlph~-?~ receptors Hhich produce 
vasoconstrict.ion and per:tpheral :Lnhibiting or beta 
13 
receptors vJ'h:l.ch vasodilate. Cardiac receptors are all 
stimulatory and are beta receptors 'V1hich increase 
contractility, i.e., inotropic and rate chronotropic. 
Norepine~)hrine and metar~'Uinol are alpha-stiJlmlatiJ:1..g 
drugs in the periphery, :l.ncreasing resistance, and beta 
st.imulati~3 for t.he heart, increasing contractility and 
rate. Phenylephrine increases resistance 'irith only a weak 
57 
effect on the heart. Methoxamine r...ydrochloride 
(Va-soxyl) I.:lnd a.:ngiotensin II (Hypertensin) are pure 
alpha-stimulating dra.gs 1-lith no direct effect on the 
heart.. E-pinephrine (AdrenB.lin) has both alpha. and beta 
st1l11ulating effects \'i'hlch generally increase resistance 
and stimulate the heart. Iso:qroterenol hydrochloride 
(Isuprel hydrochloride) and mephentermine sulfate (\vyamine 
sulfate) are pure beta-stimulating ctrt'l.gs \1'h:1.ch vasodilate 
13 
per1.pherally and stimulate the heart. Other classes 
of vasodilator agents are the alpha adrenergic blocking 
l3,.7 
agents such as phenoxybenzamine hydrochloride (Dibenzyline) 
and ganglionic blocking agents such as trimethaphan 
cemsylate (Arfonad c8~sylate). 
In traumatic or hemorrhagic shock, there is only one 
potential phYSiologic indication for the use of vasoactive 
agents, and that is for temporary elevation of a markedly 
26. 
reduced blood pressure ;"rhich might produce cardiac arrest 
l"')efore blood and fluids can be given. Even then, a fe11' 
hundred milliliters of saline solution viill usually begin 
to elevate the blood pressure. 
The sig!l..ificance of studies of blocking agents 
or vasodilators has been difficult to interpret in hemor-
rha51c shock because of decI'eased blood los s vlhen the 
agent is given before the shock and the necessity to 
restore blood volume if such agents are given duri~~ shock. 
The beneficial effect of these agents has been thought to 
be due to reversal of the loss of plasma volu.,'ne produced 
by vasoconstriction, decreased res:1.stsmce with improved 
blood flow' to tissues, and a decreased vlork load of the 
heart. 
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Lillehei has been one of the pioneers in the study 
and clinical use of phenoxybenzam:Lne hydrochloride in 
shock "fhen volume replacement has not produced improvement, 
and has reported clinical improvement and survival in 
otheI'1vise unrespor!.S ive patients. He stresses the importance 
of adequate blood volume replacement v;i'th the use of the 
ctrug, vihich is given in a dose of one milligram per 
kilogram intravenously over all hour period. 
- 20 
the drug per'Sists for about 24 hO'lJ.rs. 
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MacLean in studies of' sever'e or unrespor...sive shock 
in man, found that isoproterenol lilas the dru.g of choice 
1111.en volume l .... eplacement 11£:1d elevated the central venous 
pressure b' .... 1t not im~)1"oved arterial PreSBure and. cardi~lc 
output. Isoproterenol has a marked ct'lrdiac inotropic 
22 
effect, increlStses heart rate, and prod:"1".1ces vasodilatation. 
HOi'leVer, \';hen it is given to the ~oatient h1. shock ,'d th a 
high C611.tral venous pressure, blood pressure ,,!ill frequently 
rise because of the iml')roved cardiac output. One to t\10 
milligrams in 500 milliliters of dextrose and '1:Iater is 
g:i.ven at a slm-7 rate not exceeding 15 to 20 drops per 
minute. Tachycardia may be a problem and careful titr,9,~"ion 
is necessary. 
In summary it may be said that the use of vasoconstrictor 
agents viill probably decrease in the treatment of shock 
and that the vasoactive agents of' choice 1rrill be drugs 
such as isoproterenol for patients u.nresponsive to volume 
replacement IOtnd other measures. The use of vasoactive 
e~gents is unsound if blood volume has not been adequately 
replaced as evidenced by central venous pressure measurem~:mt. 
lim'lever, they may be neceasary for short term use '\"lhen a 
fall in blood presaure has been so sudden 13.nd severe that 
arrest is iu"1r!linent. III this instance a vasopressor 
agerrG may be lifesaving until fluids or blood can be given 
and other problems corrected. 
~mTABOLIC ACIDOSIS 
In shock there 1s a decreased carbon dioxide content 
of the blood. This 'liaS first confirmecl in vlorld "iie,r ! 
12 
casualt:i.es by Ca:n ... '1.on. The metabolic acidosis produced 
during severe shock by cell :b.yPOXl,a., anaerobic glycolysis, 
28. 
and increased acid metabolites rillS been thought to be 
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harmful and to further depress the circulation. As 
previously noted, the most iml;ortant problem caused by 
acidosis in the human m.e.y be the propensity to cardiac 
arrest or ventricular fibrillation. 
The arterial pH in patlents in shock may be as lov;/, as 
7.1, but is more frequently at levels of 7.25 to 7.35 
because of respiratory compensation. SodiU!l1 bicarbr.)nate 
is the most available and useful alkal:i.nizing agent for 
treatment of acidosis, and some use it empirj.cally in all 
patients vlith severe shock. Frequently this is not 
necessary, and documentation of the pl"oblem by measurement 
of pH and bicarbonate concentration or pC02 of arterial 
blood should be obte.ined vlhenever possible. Since large 
amou,"0.ts of sodium blc8.1"bol1.ate 1'Jith sizable sOdi.1.L'11 and 
1tlater loads may be necessary to correct grossly abnormal 
pII, ft more potent bufferi,n.e; agent, Tl1all or ffris b'uffer 
(tromethamine) r.tas been studied. It has the ability to 
penetrate cells, but v'ihether this intracellular buffering 
is advantageous is not knovln. It is, hmvever, a potent 
hydrogen ion acceptor and has the distinct a.dvantage of 
su·pplyj.ng buffer vlithout sod:i.llill ion. It is also cap;3.ble 
of promoting osmotic diuresis. Respiratory delJression 
is COIrL11l0n, and ventilatory support must be avai.loble. In 
5 
a recent revie\·,r, Bleich 8.nd Schv18rt z found nothir~ to 
recommend Th-3..111 over sodium bicarbonate in the treatment 
met.a.bolic acidos is. Hence, tb.e plE'l.ce of Them in the 
treatment of shock is not definitely established, but it 
may be of some use. 
STJi:ROIDS 
Hemorrhagic shock may develop in patients 1,ij.th adrenal 
ir...sufficiency or those previously receiving steroids. 
Since a rare patient may have aClJ.te adrenal corM .. cgl irtsui'-
ficiency in such a situation and can be resuscitated by 
small doses of steroids, this empirical approach cannot 
be condemned in a desperate situation. .fA plasma sample 
for later corticosteroid determination may be helpful in 
proving the deficiency state. The use of massive doses of 
steroids in some forms of shock: has become COill..!'Tlon practice, 
19 
but ",rill not be reviev16d here. 
Off HER CONSI DERi'~:rI ONS 
Dip;it,'3.lis. The physician treatir..g a l:'atient "d.th high 
centr,'Jl venous pressure and inadequate cardiac output should 
consider the use of digitalis. Digitalization :i"s justi.fied 
in any patient in shock refract or"'" to fluid therapy, 
beta inotrOIJ:lc c8.1""<1iac stimulants, and alpha adrenolytic 
agents. Digit,,,.lis preparat:tons are synergistic with 
13 
iso:proterenol. 
Hy"Ootherrnia. The potential usefulness of hypothermla h1 
the treatment of shock has been demonstro"ted. lL.'1 exponential 
fall tn oxygen consumption occurs \'iith decreas:i .. rl\:3 body 
temperature indicating a decreased demand for oxygen by 
30. 
by cells. Hypothermia, however, 11:'2_S not been used extensively. 
Tv'!Q 11.19\1191" methods for reducing cellular oxygen demand 
are intravenous infusions of hypertonic glucose and 
magnesiUt'll. Neither method has had clinical application, 
b"l1t the concept of i11duci:ng a state of reduced oxygen demand 
13 
may playa role in the 1"uture treatment of shock. 
Poai tion of the Patient. The Trendelel1burg pos1.tion has 
been used to treat shock, but vital capacity is decreased. 
The only reason for its use is to empty the ve:1.n8 of the 
legs, which may be the equivalent of a si~~le blood 
transfusi.on. This can be qUi.ckly accomplished by raisir'..g 
the legs alone. 
Observations obtained from careful, partially controlled 
stUdies in humans vdth major bleedir..g have changed sorne 
classic concepts of shock management. The patient in 
shock must be observed by measurement of arterial blood 
pressure, urine output, and central venous pressure, in 
addition to general observations including skin color and 
capillary circulation. EssentiE'cl laboratory studies for 
the d:iff'icult problem include determinations of serum 
electrolytes and aterial blood pH, p02' and pC02 • Restor-
ation and maintenance of an effecti va circulatin,g blood 
vo1t:llUe should be carrieQ out us:lng 1;lho1e b1ood, clinical 
dextran, saline, or Ringer's lactate solution. The use 
of saline solutions in add:ltion to blood may be helpful. 
31. 
If arterial l)reSSUre and ur'i.ne output do not respond 
satisfactorily to volume replacement and central venous 
pressure rises, drugs iilhi.ch increase myocardial contractility 
such as isoproterenol and digitalis, should be consi.dered. 
D~ugs which produce vasoconstriction and i.ncrease myocardial 
contractility such as norepinephrine or aramine must be 
used cautiously in attempts to produce pri.marily an 
inotropic effect on the heart. 
Improvement of alveolar ventilation, correction of 
metabolic acidosis, and replacement of continuing losses 
of blood -and fluids may be critical. Mannitol seems to 
be helpful in protecting the kidneys, and low molecular 
ille::tght dextran may help in 1..mproving blood flol'! :i.n the 
microcirculation. The most frequent causes of lack of 
responsiveness to treatment are unrecognized volume 
deficits or continuing losses of blood volume, inadequate 
replacement of losses, myocardial fai.lure, severe sepsis, 
peripheral poolir;.g of blood volume, iJ:"l..8,dequate ventilation 
v'Tith hypoxia or carbon dioxide retention, or both, 
pel"sistent metabolic aCidosis, hyponatremia, hyperlcalemia, 
hypocalcemia, and renal failure. 
Measures directed at decreasing peripheral resistance, 
increasing cardiac output, and providing support for lu:ng 
'-.lnd kidney should be included in the treatment. Iv1onitorir..g 
techniques have increased in sophistication, but intelligent, 
careful, minute-to-m:tnute bedside observation remains the 
most importa:n:t. guide in care of the shock pa.tient. 
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